Sex Differences in Treatment Expectations, Satisfaction and Tolerance After Switching to CT-P17, an Adalimumab Biosimilar: A Post Hoc Analysis of the YU-MATTER Study

Abstract Introduction Data suggest that women and men differ in how they experience biological treatment. This post hoc analysis of the YU-MATTER study evaluated sex-related differences in patient satisfaction and perception when switching from adalimumab (reference or biosimilar) to CT-P17 (Yuflyma...

Повний опис

Бібліографічні деталі

Автори:	Laure Gossec, Guillaume Bouguen, Azeddine Dellal, Lucile Foulley, Caroline Habauzit, Salim Benkhalifa, Hubert Marotte
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Adis, Springer Healthcare 2026-03-01
Серія:	Rheumatology and Therapy
Предмети:	Adalimumab Adverse events Biosimilar CT-P17 Injection site reactions Patient-reported outcomes
Онлайн доступ:	https://doi.org/10.1007/s40744-026-00840-7
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!